Table 7 Details on the primary outcome
pre-CPDX screening (n = 4) | CPDX screening (n = 19) | |
|---|---|---|
Modified, n (%) | ||
SBT/ABPC—> MEPM | 0 (0) | 1 (5.3) |
PIPC—> MEPM | 0 (0) | 1 (5.3) |
TAZ/PIPC—> MEPM | 0 (0) | 2 (10.5) |
CTRX—> MEPM | 1 (25) | 7 (36.8) |
SBT/CPZ—> MEPM | 0 (0) | 1 (5.3) |
CFPM—> MEPM | 0 (0) | 2 (10.5) |
SBT/CPZ—> TAZ/PIPC | 0 (0) | 1 (5.3) |
CTRX—> CMZ | 0 (0) | 2 (10.5) |
Initiated, n (%) | ||
MEPM | 2 (50) | 0 (0) |
CMZ | 0 (0) | 2 (10.5) |
SBT/CPZ | 1 (25) | 0 (0) |